3-155826533-GTTTT-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_004733.4(SLC33A1):c.*1673_*1676delAAAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0849 in 151,928 control chromosomes in the GnomAD database, including 709 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.085 ( 709 hom., cov: 31)
Failed GnomAD Quality Control
Consequence
SLC33A1
NM_004733.4 3_prime_UTR
NM_004733.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.369
Genes affected
SLC33A1 (HGNC:95): (solute carrier family 33 member 1) The protein encoded by this gene is required for the formation of O-acetylated (Ac) gangliosides. The encoded protein is predicted to contain 6 to 10 transmembrane domains, and a leucine zipper motif in transmembrane domain III. Defects in this gene have been reported to cause spastic paraplegia autosomal dominant type 42 (SPG42) in one Chinese family, but not in similar patients of European descent. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 3-155826533-GTTTT-G is Benign according to our data. Variant chr3-155826533-GTTTT-G is described in ClinVar as [Likely_benign]. Clinvar id is 343855.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC33A1 | ENST00000643144 | c.*1673_*1676delAAAA | 3_prime_UTR_variant | 6/6 | NM_004733.4 | ENSP00000496241.1 | ||||
ENSG00000284952 | ENST00000643876.1 | n.*1000+1645_*1000+1648delAAAA | intron_variant | ENSP00000495323.1 |
Frequencies
GnomAD3 genomes AF: 0.0850 AC: 12903AN: 151810Hom.: 710 Cov.: 31
GnomAD3 genomes
AF:
AC:
12903
AN:
151810
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0849 AC: 12893AN: 151928Hom.: 709 Cov.: 31 AF XY: 0.0814 AC XY: 6047AN XY: 74246
GnomAD4 genome
AF:
AC:
12893
AN:
151928
Hom.:
Cov.:
31
AF XY:
AC XY:
6047
AN XY:
74246
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
150
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Spastic paraplegia, autosomal dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at